A 6-gene signature identifies four molecular subgroups of neuroblastoma
<p>Abstract</p> <p>Background</p> <p>There are currently three postulated genomic subtypes of the childhood tumour neuroblastoma (NB); Type 1, Type 2A, and Type 2B. The most aggressive forms of NB are characterized by amplification of the oncogene <it>MYCN </it...
Main Authors: | Kogner Per, Stallings Raymond, Vermeulen Joëlle, De Preter Katleen, Jörnsten Rebecka, Nethander Maria, Dalevi Daniel, Abel Frida, Maris John, Nilsson Staffan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/11/1/9 |
Similar Items
-
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
by: Enström Camilla, et al.
Published: (2011-02-01) -
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
by: Kogner Per, et al.
Published: (2009-08-01) -
Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma.
by: Agnes Rasmuson, et al.
Published: (2012-01-01) -
A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma.
by: Eveline Barbieri, et al.
Published: (2013-01-01) -
Integrative discovery of treatments for high-risk neuroblastoma
by: Elin Almstedt, et al.
Published: (2020-01-01)